ACRS
Aclaris Therapeutics Inc.
$1.94
+$0.06(+3.48%)
48
Overall
60
Value
40
Tech
44
Quality
Market Cap
$199.33M
Volume
532.19K
52W Range
$1.05 - $5.17
Target Price
$7.86
Key Metrics Overview
| Market Cap | $199.33M | P/E Ratio | N/A |
| 52W High | $5.17 | 52W Low | $1.05 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -2.2% | 52W Position | 21.5% |
| Overall Score | 48 | Value Score | 60 |
| Quality Score | 44 | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-0.51 | EPS Next Est | $-0.54 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACRS | $1.94 | +3.5% | 532.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aclaris Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW